Only as available as its most restricted ingredient, here, injectable GHK-Cu, which is not available.
GLOW stack
GLOW adds a copper peptide (GHK-Cu) to the Wolverine base, a three-peptide blend pitched for skin, collagen, and tissue repair, usually sold as a single injectable.
Last reviewed June 16, 2026.
The honest answer
GLOW takes the Wolverine repair pair and adds GHK-Cu, a copper peptide, for a skin-and-appearance tilt, collagen, matrix, tone. Two things matter before anything else: it's sold as a single injectable, and topical cosmetic GHK-Cu is a completely different, legal product from the injectable form used here. As a blend it has never been tested in a clinical trial.
- GHK-Cu is one of the better-studied copper peptides for collagen and matrix signaling, as a topical cosmetic.
- BPC-157 and TB-500 carry the same animal-model repair evidence they do in Wolverine.
- The GLOW combination has never been studied as a product in any clinical trial.
- It has even less combination evidence than Wolverine.
- None of the three is FDA-approved for these uses.
Go deeper
The concept is three-axis coverage: BPC-157 for local tissue signaling, TB-500 for systemic cell migration, and GHK-Cu for matrix and collagen remodeling, a repair base with a skin-quality layer on top. That's the rationale people give for the blend. It's mechanistic reasoning, not a tested result, and it says nothing about how the blend should be used, which is a clinical question, not a recipe.
Anything on this page about GLOW refers to injectable blends, which we do not offer. Topical copper peptides for skin are a separate, legal category, see the Skin & Hair goal.
GLOW sits one rung up from Wolverine: it adds a peptide, and with it more variables and less combination evidence, not more proof.
| Stack | What it adds | Combination evidence |
|---|---|---|
| WolverineBPC-157 + TB-500 | The base repair pair | Animal-model data on each member; none on the combination |
| GLOW+ GHK-Cu | A copper peptide, tilting toward skin and appearance | Even less combination evidence than Wolverine |
| KLOW+ KPV | An anti-inflammatory, gut-leaning peptide | The least combination evidence of the three |
Status & access
GLOW is an injectable blend, so we treat it as education only and do not offer it. Injectable GHK-Cu is restricted and under review for early 2027, it is not available. BPC-157 and TB-500 are on the July 23, 2026 PCAC agenda (advisory).
Compounded medications are prepared for an individual patient and are not FDA-approved. Removal from FDA Category 2 (April 2026) is not approval and not 503A Bulks-List eligibility. PCAC is advisory, a favorable vote leads to rulemaking, not instant availability.
Anything on this page about GLOW refers to injectable blends, which we do not offer. Topical copper peptides for skin are a separate, legal category, see the Skin & Hair goal.
Questions, answered first
What is the GLOW stack?
GLOW is a three-peptide injectable blend, the Wolverine pair (BPC-157 + TB-500) plus injectable GHK-Cu, a copper peptide, pitched for skin, collagen, and tissue repair. It's a community blend, not a clinical product, and it has never been studied as a combination.
Is injectable GHK-Cu legal?
No, injectable GHK-Cu is restricted and under FDA review projected for early 2027; it is not available. This is different from topical cosmetic GHK-Cu, which is an established, legal skincare ingredient. We never let the topical's legality imply the injectable's.
Is GLOW the same as topical copper peptide serums?
No. The copper peptide in a cosmetic serum (topical GHK-Cu) and the injectable GHK-Cu in a GLOW blend are different products with different rules. Topical is legal and available; the injectable blend is not. If you're after skin benefits, the topical/cosmetic route is the legal one, see the Skin & Hair goal.